Latest "Gleneagles Clinicial Research Centre Pte. Ltd" News Stories

08:27 EDT 26th September 2018 | BioPortfolio

Here are the most relevant search results for "Gleneagles Clinicial Research Centre Pte. Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Gleneagles Clinicial Research Centre Pte. Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Gleneagles Clinicial Research Centre Pte. Ltd for you to read. Along with our medical data and news we also list Gleneagles Clinicial Research Centre Pte. Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Gleneagles Clinicial Research Centre Pte. Ltd Companies for you to search.

Showing "Gleneagles Clinicial Research Centre" News Articles 1–25 of 28,000+

Wednesday 26th September 2018

Humanetics Corporation Presents Data on New Drug to Prevent Radiation Injury

Data supports the ongoing development of new drug candidate, BIO 300, to prevent radiation injury from a radiological or nuclear event. Humanetics Corporation (Humanetics) has been invited to present data at the 64th Annual Meeting of the Radiation Research Society (RRS) being held September 23rd through the 26th in Chicago, IL. Adam Harvey, Ph.D., of ...

BioTalent Canada Announces Health City’s CEO as New Board Chair

Today, BioTalent Canada announced Reg Joseph, Health City’s Chief Executive Officer, as the new Chair of their Board of Directors. Mr. Joseph has served on BioTalent Canada’s Board of Directors since 2014, most recently as Vice-Chair. His background in successfully growing organizations from both an Executive and Board level will be an ...

Chan Zuckerberg Biohub Awards $13.7 Million to Fund New Intercampus Collaborative Research Programs to Advance Human Health

New funding from CZ Biohub fosters further scientific research collaboration between Stanford, University of California, Berkeley, and University of California, San Francisco CZ Biohub Microbiome Initiative and Intercampus Research Awards provide grant funding to teams that include an interdisciplinary group of 42 project le...

Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic

Selexis SUREtechnology Platform™ Successfully Expresses Hoba’s HB-086 in CHO Cells Selexis SA and Hoba Therapeutics announced today that they have entered into an

Grant Application Deadline Extended to November 15th for Researchers Investigating Causes/Treatments of Job Syndrome

Job Research Foundation will award a pair of two-year grants of up to $200,000 each, and a pair of two-year grants of up to $50,000 each to qualified grantees for research into the causes and treatments of the rare multisystem immunodeficiency disorder called Job Syndrome; and the deadline has been extended to November 15, 2018 and grants will be awarded on December 17th. NEW YORK (PRWEB) Septembe...

Older adults taking herbal remedies alongside prescription medicines at risk of harmful interactions

More than a million older adults in the UK could be at risk of a potential herb-drug or supplement-drug interactions, research shows.

NICE decision could limit future development of CAR T therapies; Evelyn Warner comments on NICE's decision making process  #Kymriah #Novartis #NICE

NICE decision could limit future development of CAR T therapies; Evelyn Warner comments on NICE's decision making process  #Kymriah #Novartis #NICE #Research

Major London Hospital uses ProtoCOL 3 Automated Colony Counter To Rapidly and Accurately Track Spread of Antibiotic Resistant Superbugs

Cambridge, UK: Synbiosis, a long-established, expert manufacturer of automated microbiological systems, is pleased to announce its ProtoCOL 3 automated colony counter is being used at a major teaching hospital in London to accurately track the spread of Carbapenem-Resistant bacteria (CRB) superbugs. Microbiologists in the infection control group at the hospital are using ProtoCOL 3 to count co...

Potent chemical agents that can thwart cancer metastasis found

a research team led by Maurizio Pellecchia at the University of California, Riverside, discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumour...

High Temperature Clean Room Ovens up to 600°C

CARBOLITE GERO is a leading manufacturer of high temperature ovens and furnaces from 30°C to 3000°C. With more than 100 years of experience in thermal engineering our products are used in research laboratories, pilot plants and manufacturing sites worldwide. Many of CARBOLITE GERO's ovens and furnaces are built to suit a clean room environment. Depending on a customer's requirement, it may...

ACEA Biosciences to be Acquired by Agilent Technologies

Cell Analysis Just Got Better! ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries. In recent years, the ACEA xCELLi...

Epwin Group (EPWN) - Some positive trading aspects in lower H1

Edison Investment Research - Construction & Building Materials - Epwin Group: Lower H118 profit and a greater H2 bias were both well trailed by management. Each reporting division had its trading headwinds, but also saw some positive underlying performances. Footprint consolidation projects are progressing and these developments should complement the usual seasonal improvement in H2 profitability....

Ranking the top ten clinical research organisations in the world

Clinical research organisations support pharmaceutical companies during the research and development (R&D) phase by providing a way for some of...Read More... The post Ranking the top ten clinical research organisations in the world appeared first on Pharmaceutical Technology.

Bioasis Technologies Inc BTI Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryBioasis Technologies Inc BTI is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company's transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across the blood brain barrier. It commercializes its business operations through Cognitest and Transcend names...

DuPont Nutrition & Health Research Study Demonstrates a Role for Nasal Microbiota in the Host Response to Viral Respiratory Infection

The DuPont Microbiome Venture and Global Health & Nutrition Science teams have worked in collaboration with the University of Virginia and 4Pharma Ltd. KANTVIK, Finland (PRWEB) September 26, 2018 A collaborative clinical study between DuPont Nutrition & Health, the University of Virginia and 4Pharma Ltd indicates that nasal microbiota may influence the viral load, host innate immune respo...

Roche: IMpower 133 - Praxisverändernde Daten zur Erstlinienbehandlung von ES-SCLC präsentiert

Zürich ( - Roche-Aktienanalyse von Aktienanalyst Stefan Schneider von Vontobel Research: Stefan Schneider, Aktienanalyst von Vontobel Research, rät in einer aktuellen Aktienanaly...

Partners HealthCare System Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryPartners HealthCare System Inc PHS is a nonprofit integrated healthcare organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and longterm care centers, community health centers and other healthcare entities. The organization focuses on providing patient care, research, teaching, and other services to patients ...

Tuesday 25th September 2018

Micell Technologies Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryMicell Technologies Inc Micell is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company offers product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drugeluting stent that is designed to optimize healing. It provides novel drugcoated balloon to deliver sirolimus to the artery wall at the site of...

Foundation Radiology Group PC Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryFoundation Radiology Group PC FRG is a radiology solutions provider. The company provides radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It provides imaging solutions for the radiologists and systems to the existing radiology department. FRG's solutions include programmatic strategic alignment, multi...

Bridging the gap between psychology and gamification

A multi-disciplinary research team is bridging the gap between psychology and gamification that could significantly impact learning efforts in user experience design, healthcare, and government.

Cash gift offered to NTU Singapore to establish new postdoctoral fellowship program

The Knut and Alice Wallenberg Foundation, the largest private financier of research in Sweden, is making a S$9 million cash gift to Nanyang Technological University, Singapore (NTU Singapore) to establish a new postdoctoral fellowship program to support up to 40 fellows over the next six years.

Trump administration launches sweeping review of fetal-tissue research

PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceutical

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based Santen Pharmaceuticals Co., Ltd., (“Santen”). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform Syste...

NIH-funded genome centers to speed up breakthroughs in precision medicine

The All of Us Research Program awarded funds totaling $28.6 million to establish three genome centers around the country. These centers will begin to generate genomic data from biosamples contributed by the program's participants.

#jobs #lifescience Wellcome Sanger Institute: Postdoctoral Fellow – Cellular Genetics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Wellcome Sanger Institute: Postdoctoral Fellow – Cellular Genetics . Salary in the region of £31,503 – £39,492 (dependent on experience) plus excellent benefits: Wellcome Sanger Institute: Job Reference 83222 Postdoctoral Fellow – Cellular Gene...

Quick Search


News Quicklinks